The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

ECbiotech Taiwan108 enrolled

Overview

The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.

The researchers have the animal model that the extract of the Agaricus blazei Murill mushroom is effective in the treatment of type II DM mice conducted on 2002. The dose effects were also found. The researchers conducted the pilot study also showing the same effects in 2003. So the researchers designed this trial. The elixir of the Agaricus blazei Murill mushroom is popular in Taiwan for chronic diseases, such as type II DM.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

108

Conditions

Diabetes Mellitus, Type II

Interventions

Extract of Agaricus blazei MurillDRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Type II DM * Age 20-75 years old * Treat with Gliclazide and Metformin * Signed informed consent Exclusion Criteria: * GOT/GPT \>80/80 * Creatinine \> 2.0 * Lactating or pregnant women

Locations (1)

Chung-Hua Hsu

Taipei, Taiwan

Outcomes

Primary Outcomes

Percent reduction of glycated hemoglobin (HAb1C) and insulin resistance(HOMA-IR)

Secondary Outcomes

Glucose, cholesterol, triglyceride, leptin, adiponectin comparisons

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.